Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	188.58B
Revenue (ttm)	19.11B
Net Income (ttm)	2.44B
Shares Out	208.86M
EPS (ttm)	11.88
PE Ratio	75.98
Forward PE	66.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	402,038
Average Volume	762,026
Open	903.40
Previous Close	900.20
Day's Range	884.10 - 906.00
52-Week Range	636.10 - 909.95
Beta	n/a
RSI	63.82
Earnings Date	Jul 16, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2024, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.